BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc. (BBOT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BBOT · as of Jun 8, 2026
Key Statistics
Explore BridgeBio Oncology Therapeutics Inc. Data
bbot stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The BBOT analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $22.00, representing +180.97% upside from the current price of $7.83.
Competitors & Peers
bbot competitorsBBOT
ANAB
KOD
MNMD
NRIX
OCSStock Performance
Full HistoryAbout BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes…
what is bridgebio oncology therapeutics inc. · bbot stock overview · bridgebio oncology therapeutics inc. company profile · who is bridgebio oncology therapeutics inc. ceo · bbot NASDAQ · bridgebio oncology therapeutics inc. headquarters · bridgebio oncology therapeutics inc. business segments
About Stock Overview & Key Data
BridgeBio Oncology Therapeutics Inc. (BBOT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 12, 2025. As of the latest trading session, BBOT stock price is $7.83, with a market capitalization of $627.2M. The stock has returned -28.03% over the past 12 months and -37.46% year-to-date.
According to 3 Wall Street analysts, the consensus rating for BridgeBio Oncology Therapeutics Inc. stock is Buy, with an average 12-month price target of $22.00. In fiscal year 2025, BridgeBio Oncology Therapeutics Inc. reported revenue of — and net income of -$134.0M. For detailed data — including BridgeBio Oncology Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BridgeBio Oncology Therapeutics Inc. (BBOT) stock price is $7.83. The stock is traded on NASDAQ under the ticker symbol BBOT. The 52-week range is $7.60 – $14.87.